China · Delayed Price · Currency is CNY Well Lead Medical Statistics
Total Valuation
SHA:603309 has a market cap or net worth of CNY 3.09 billion. The enterprise value is 3.21 billion.
| Market Cap | 3.09B |
| Enterprise Value | 3.21B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
SHA:603309 has 291.87 million shares outstanding. The number of shares has decreased by -1.26% in one year.
| Current Share Class | 291.87M |
| Shares Outstanding | 291.87M |
| Shares Change (YoY) | -1.26% |
| Shares Change (QoQ) | -2.62% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 9.16% |
| Float | 142.57M |
Valuation Ratios
The trailing PE ratio is 93.32 and the forward PE ratio is 9.81.
| PE Ratio | 93.32 |
| Forward PE | 9.81 |
| PS Ratio | 1.87 |
| PB Ratio | 1.68 |
| P/TBV Ratio | 2.04 |
| P/FCF Ratio | 13.20 |
| P/OCF Ratio | 7.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.17, with an EV/FCF ratio of 13.71.
| EV / Earnings | 97.40 |
| EV / Sales | 1.94 |
| EV / EBITDA | 9.17 |
| EV / EBIT | 12.78 |
| EV / FCF | 13.71 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.32.
| Current Ratio | 1.78 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.32 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 2.55 |
| Interest Coverage | 34.55 |
Financial Efficiency
Return on equity (ROE) is 2.41% and return on invested capital (ROIC) is 7.05%.
| Return on Equity (ROE) | 2.41% |
| Return on Assets (ROA) | 5.49% |
| Return on Invested Capital (ROIC) | 7.05% |
| Return on Capital Employed (ROCE) | 11.01% |
| Weighted Average Cost of Capital (WACC) | 2.91% |
| Revenue Per Employee | 581,832 |
| Profits Per Employee | 11,584 |
| Employee Count | 2,849 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 4.56 |
Taxes
In the past 12 months, SHA:603309 has paid 37.33 million in taxes.
| Income Tax | 37.33M |
| Effective Tax Rate | 45.02% |
Stock Price Statistics
The stock price has decreased by -26.64% in the last 52 weeks. The beta is -0.17, so SHA:603309's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | -26.64% |
| 50-Day Moving Average | 11.20 |
| 200-Day Moving Average | 12.88 |
| Relative Strength Index (RSI) | 39.16 |
| Average Volume (20 Days) | 2,525,189 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603309 had revenue of CNY 1.66 billion and earned 33.00 million in profits. Earnings per share was 0.11.
| Revenue | 1.66B |
| Gross Profit | 706.07M |
| Operating Income | 251.51M |
| Pretax Income | 82.93M |
| Net Income | 33.00M |
| EBITDA | 335.05M |
| EBIT | 251.51M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 493.55 million in cash and 598.05 million in debt, with a net cash position of -104.50 million or -0.36 per share.
| Cash & Cash Equivalents | 493.55M |
| Total Debt | 598.05M |
| Net Cash | -104.50M |
| Net Cash Per Share | -0.36 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 6.31 |
| Working Capital | 416.70M |
Cash Flow
In the last 12 months, operating cash flow was 402.67 million and capital expenditures -168.20 million, giving a free cash flow of 234.47 million.
| Operating Cash Flow | 402.67M |
| Capital Expenditures | -168.20M |
| Depreciation & Amortization | 83.54M |
| Net Borrowing | -21.64M |
| Free Cash Flow | 234.47M |
| FCF Per Share | 0.80 |
Margins
Gross margin is 42.59%, with operating and profit margins of 15.17% and 1.99%.
| Gross Margin | 42.59% |
| Operating Margin | 15.17% |
| Pretax Margin | 5.00% |
| Profit Margin | 1.99% |
| EBITDA Margin | 20.21% |
| EBIT Margin | 15.17% |
| FCF Margin | 14.14% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 5.66%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 5.66% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 476.16% |
| FCF Payout Ratio | 62.24% |
| Buyback Yield | 1.26% |
| Shareholder Yield | 6.92% |
| Earnings Yield | 1.07% |
| FCF Yield | 7.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 25, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 25, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |